Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of MicroRNA31 Precursor Encoded Polypeptide in the Preparation of Immunomodulatory Drugs

A technology of immunomodulatory drugs and drugs, applied in the field of biomedicine

Active Publication Date: 2020-02-14
SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is currently no cure for multiple sclerosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of MicroRNA31 Precursor Encoded Polypeptide in the Preparation of Immunomodulatory Drugs
  • Application of MicroRNA31 Precursor Encoded Polypeptide in the Preparation of Immunomodulatory Drugs
  • Application of MicroRNA31 Precursor Encoded Polypeptide in the Preparation of Immunomodulatory Drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0088] Example 1, miPEP31 sequence analysis and in vitro synthesis

[0089] 1. miPEP31 sequence analysis

[0090] The sequence of the miR-31 precursor is as follows:

[0091] ACGTAACCTAAAGCTAACAGACGGGGAAGCCATCACCAGGGTTTGGGTTGGATTCCCTACCAGTAAAATGAGGTAATGATGTGAAATTGGTCACGTTGTTGAAGAGTTGAA CTGTTGAACTGAGAACCTGCTATGCCAACATATTGCCATCTTTCCTGTCTGACAGCAGCTTGGCTACCTCCGTCCTGTTCCTCCTTGTCTTGCTACAAGCCATCCATGATATGTAGGGCCCTGTGACTTGGTCTGTCTCGCCCTGACTTCTCTCCAGTCCTATACCGAATCACTCGCTCTGTTCTAGCCACACTGGCCTTTTGGGGATGTTCTTGGCTGCACCAGGAATATTCCCGCCTCTACTGCCCTGTCTTATCTTTTGGGCATCAGTGGAGAACTCTTTCACCATGGCACTGTCTATAAAACCTTACATGTGCCCAGCCACCGTTCACCTCATGACCCTGCTCTGACTTGTCAGAATCATTGGGCACTACCTGTCCATGTTCATTTGCTTAGTTGCTGCTTGATTTACTGTACCAGGTTGTAAGTCCTTTAAGGGACACCCGTCTTCATTTCTGTTCACCATACCCCTAAACCCTGACGTTTGCAAGTCCTCAAGTCATGTCTTTGCGACTCTACCCTGGACTTATTGTGCAACAGAAGTGTCAAATAATGAGATTTTAATCATGCCATGAATGGCTGTGATGAAACACTGGTTTATAAGTAACAAAGAATAAACAAATGCTACTGATTTCTAAGCCTGCAAACCCAACATCTTAAAGGAGCCACAATAAAGTTACCATCAGGTCTACAACTCAG...

Embodiment 2

[0095] Example 2, expression of miPEP31 in cells

[0096] The coding sequence of miPEP31 was constructed into the Sal1 / Xhol1 restriction site of plasmid pEGFP-N1 (Addgene). Thus, the obtained heavy plasmid can form a fusion protein of miPEP31 and GFP after expression.

[0097] The recombinant plasmid obtained above was transfected into adipocyte precursor cells (3T3), and adipocyte somatic cells transformed with empty plasmid (pEGFP-N1blank) were used as a control. The blank group was only transfected with a blank GFP plasmid, and the miPEP31 group was transfected with both miPEP-GFP and GFP empty plasmids.

[0098] Cells were cultured, and after protein extraction, the expression of GFP was detected by electrophoresis-immunoblotting. The results were as follows: figure 1 .

[0099] The expression of GFP could be detected in the empty plasmid group, and two GFP bands were detected in the miPEP31 group, and one of them had a larger molecular weight, which was miPEP31 fused w...

Embodiment 3

[0103] Example 3, exogenously synthesized miPEP31 can enter cells

[0104] The miPEP31 miPEP obtained by the solid-phase peptide synthesis method in Example 1 is labeled with FITC at its C-terminus.

[0105] 1. 3T3 cells

[0106] 1nM FITC-labeled miPEP31 was co-cultured with 3T3 cells, and the FITC fluorescence of the cells was detected by flow cytometry. The result is as image 3 A, FITC signal can be observed in the cells, indicating that miPEP can enter 3T3 cells.

[0107] After the 3T3 cells were fixed, the nuclei were stained with DAPI, and then the fluorescence was observed with a confocal laser microscope. The result is as image 3 c. The nuclei were stained with DAPI, and blue fluorescence could be observed.

[0108] 3T3 cells were co-cultured with 1nM FITC-labeled miPEP31; after that, the cells were fixed, the nuclei were stained with DAPI, and the fluorescence was observed with a confocal laser microscope. The result is as image 3 From D to E, green fluoresc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided is a micro RNA31 precursor polynucleotide, a polypeptide encoded thereby, and a method for preparing said polypeptide. Also provided is an application of the polynucleotide and the polypeptide for preparing immunomodulatory drugs.

Description

technical field [0001] The invention belongs to the field of biomedicine, and more specifically, the invention relates to the application of microRNA31 precursor-encoded polypeptide in the preparation of immunomodulatory drugs. Background technique [0002] Regulatory T cells (Treg for short) are a kind of T cell subsets that control autoimmune reactivity in the body, and are closely related to the occurrence of autoimmune diseases. Regulatory T cells can be divided into naturally occurring natural regulatory T cells (nTreg) and induced adaptive regulatory T cells (aTreg or iTreg), such as Th3 and Tr1, as well as CD8 Treg and NKT cells. [0003] Studies have shown that Treg is associated with type I diabetes, systemic lupus erythematosus, aplastic anemia, idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, multiple sclerosis, inflammatory bowel disease, myasthenia gravis and other diseases closely related. In addition, it is also related to the pathogenesis o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/00C12N15/11A61K38/16A61P37/02A61P29/00A61P19/02A61P17/06
CPCA61K38/00C07K14/00A61K38/16C12N15/11Y02A50/30
Inventor 王宏林
Owner SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE